daridorexant
Sign in to saveAlso known as ACT-541468, [(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone, nemorexant
Key facts
- Drug.image
- Daridorexant structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.caption
- Above: structure of daridorexant Below: 3D representation of a daridorexant molecule
- Drug.image2
- Daridorexant 3D.png
- Drug.image_class2
- bg-transparent
- Drug.USAN
- Daridorexant hydrochloride
- Drug.tradename
- Quviviq
- Drug.DailyMedID
- Daridorexant
- Drug.routes_of_administration
- By mouth
- Drug.class
- Dual orexin receptor antagonist; Hypnotic; Sedative
- Drug.ATC_prefix
- N05
- Drug.ATC_suffix
- CJ03
- Drug.legal_CA
- Rx-only
- Drug.legal_UK
- POM
- Drug.legal_US
- Schedule IV
- Drug.legal_EU
- Rx-only
- Drug.bioavailability
- 62%
via Wikipedia infobox
~16 min read
Encyclopedic overview
20 sectionsContents
- Medical uses
- Available forms
- Contraindications
- Side effects
- Overdose
- Interactions
- Pharmacology
- Pharmacodynamics
- Mechanism of action
- Pharmacokinetics
- Absorption
- Distribution
- Metabolism
- Elimination
- Chemistry
- History
- Society and culture
- Legal status
- References
- Further reading
thumb|Daridorexant blister pack sold in Japan thumb|Left: Quviviq, Right: Lemborexant|Dayvigo Quviviq tablets are triangular in shape to prevent them from rolling if dropped.
Daridorexant, sold under the brand name Quviviq, is an orexin antagonist medication which is used for the treatment of insomnia. Daridorexant is taken by mouth.
Excerpted from Wikipedia’s “daridorexant” article, available under the CC BY-SA 4.0 licence.